研究
~進歩を目指す社会のために~
製薬メーカー、大学病院等で利用される
研究用試薬・検査試薬のご紹介です。
検索結果 「PET用試薬」
商品コード | 製品名 | 核種 | フォーム | 濃度 | 販売単位△ | 容器 | 備考 |
---|---|---|---|---|---|---|---|
7160. 1000 | MDP | 1g x 1 | |||||
7050. 1000 | Mebrofenin | 1g x 1 | |||||
7000. 1000 | MIBG | 1g x 1 | |||||
7001. 1000 | MIBG (GMP) | 1g x 1 | |||||
7100. 1000 | S-Benzoyl-MAG-3 | 1g x 1 | |||||
7220. 1000 | Zinc-TBI | 1g x 1 | |||||
1910. 0001 | 16alpha-Fluoroestradiol | 1mg x 1 | |||||
4020. 0001 | (-)-2-beta-Carbomethoxy-3-beta-(4-fluorophenyl)nortropane | 1mg x 1 | |||||
4000. 0001 | (-)-2-beta-Carbomethoxy-3-beta-(4-fluorophenyl)tropane | 1mg x 1 | |||||
4050. 0001 | (-)-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)nortropane | 1mg x 1 | |||||
4030. 0001 | (-)-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)tropane | 1mg x 1 | |||||
4060. 0001 | (-)-2-beta-Carbomethoxy-3-beta-(phenyl)tropane | 1mg x 1 | |||||
4150. 0001 | 2-FE-beta-CIT | 1mg x 1 | |||||
2800. 0001 | 3-O-Benzyl-naltrindole | 1mg x 1 | |||||
2055. 0001 | 3-O-Trityl-6-O-desmethyl-buprenorphine | 1mg x 1 | |||||
5110. 0001 | 6-MOMO-BTA-0 | 1mg x 1 | |||||
5100. 0001 | 6-OH-BTA-0 | 1mg x 1 | |||||
5101. 0001 | 6-OH-BTA-0 (GMP) | 1mg x 1 | |||||
1642. 0001 | (+)-9-MeO-HNO hydrochloride | 1mg x 1 | |||||
4700. 0001 | (+-)-9-O-Desmethyl-alpha-dihydrotetrabenazine | 1mg x 1 | |||||
4710. 0001 | (+)-9-O-Desmethyl-alpha-dihydrotetrabenazine | 1mg x 1 | |||||
4720. 0001 | (-)-9-O-Desmethyl-alpha-dihydrotetrabenazine | 1mg x 1 | |||||
2110. 0001 | Acetic acid piperidin-4-yl ester hydrochloride | 1mg x 1 | |||||
2877. 0001 | alphaFEAU | 1mg x 1 | |||||
4210. 0001 | Altropane | 1mg x 1 | |||||
4200. 0001 | Altropane acid | 1mg x 1 | |||||
4201. 0001 | Altropane acid hydrochloride | 1mg x 1 | |||||
4211. 0001 | Altropane hydrochloride | 1mg x 1 | |||||
9714. 0001 | AMBA acetate | 1mg x 1 | |||||
1458. 0001 | ATSM (GMP) | 1mg x 1 | |||||
7111. 0001 | (Benzoylmercapto)acetic acid | 1mg x 1 | |||||
4140. 0001 | beta-CIT acid | 1mg x 1 | |||||
2150. 0001 | Butyric acid piperidin-4-yl ester hydrochloride | 1mg x 1 | |||||
4110. 0001 | CITFE | 1mg x 1 | |||||
4100. 0001 | CITFES | 1mg x 1 | |||||
4130. 0001 | CITFP | 1mg x 1 | |||||
3550. 0001 | CNS 5161 | 1mg x 1 | |||||
9860. 0001 | Cyclo-RGDfK | 1mg x 1 | |||||
9861. 0001 | Cyclo-RGDfK dimer trifluoroacetate | 1mg x 1 | |||||
2390. 0001 | Desmethylcarfentanil acid | 1mg x 1 | |||||
2400. 0001 | Desmethylcarfentanil, sodium salt | 1mg x 1 | |||||
3540. 0001 | Desmethyl-CNS 5161 | 1mg x 1 | |||||
1700. 0001 | Desmethylflumazenil | 1mg x 1 | |||||
5200. 0001 | Desmethyl-PD 153035 | 1mg x 1 | |||||
9863. 0001 | DOTA-cyclo(RGDfK) acetate | 1mg x 1 | |||||
9831. 0001 | DOTA-Lanreotide acetate | 1mg x 1 | |||||
9830. 0001 | DOTA-Lanreotide trifluoroacetate | 1mg x 1 | |||||
9855. 0001 | DOTA-NAPamide trifluoroacetate | 1mg x 1 | |||||
9712. 0001 | DOTA-NOC acetate | 1mg x 1 | |||||
9716. 0001 | DOTA-NOC acetate (GMP) | 1mg x 1 | |||||
9715. 0001 | DOTA-[Pro1,Tyr4]bombesin (1-14) | 1mg x 1 | |||||
9862. 0001 | DOTA-RGDfK dimer acetate | 1mg x 1 | |||||
9857. 0001 | DOTA-Sargastrin | 1mg x 1 | |||||
9770. 0001 | DOTA-TATE acetate | 1mg x 1 | |||||
9772. 0001 | DOTA-TATE acetate (GMP) | 1mg x 1 | |||||
9744. 0001 | DTPA-TOC trifluoroacetate | 1mg x 1 | |||||
9745. 0001 | DTPA-TOC trifluoroacetate (GMP) | 1mg x 1 | |||||
4190. 0001 | FECNT | 1mg x 1 | |||||
1530. 0001 | FLB 604 | 1mg x 1 | |||||
9800. 0001 | Fluoropropionyl-Galacto-RGD | 1mg x 1 |
製品は研究用試薬ですので、研究用としてお使いください。
試薬の中には医薬用外毒物や医薬用外劇物を含有している場合がありますので、取扱い、廃棄には十分ご注意下さい。
使用の際には必ず添付文書または使用説明書を参照の上ご使用下さい。